These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26659129)

  • 21. Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations.
    Shibano M; Kubota T; Kokubun N; Miyaji Y; Kuriki H; Ito Y; Hamanoue H; Takahashi MP
    Muscle Nerve; 2022 Dec; 66(6):757-761. PubMed ID: 36116128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
    Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
    Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periodic paralysis.
    Fialho D; Griggs RC; Matthews E
    Handb Clin Neurol; 2018; 148():505-520. PubMed ID: 29478596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The construction and preliminary investigation of the cell model of a novel mutation R675Q in the SCN4A gene identified in a Chinese family with normokalemic periodic paralysis].
    Wu L; Wu W; Yan G; Wang X; Liu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):629-32. PubMed ID: 19065518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for gating pore current in periodic paralysis.
    Jiang D; Gamal El-Din TM; Ing C; Lu P; Pomès R; Zheng N; Catterall WA
    Nature; 2018 May; 557(7706):590-594. PubMed ID: 29769724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel De Novo Heterozygous SCN4a Mutation Causing Congenital Myopathy, Myotonia and Multiple Congenital Anomalies.
    Waldrop M; Amornvit J; Pierson CR; Boue DR; Sahenk Z
    J Neuromuscul Dis; 2019; 6(4):467-473. PubMed ID: 31609695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis.
    Estephan EP; Zambon AA; Thompson R; Polavarapu K; Jomaa D; Töpf A; Helito PVP; Heise CO; Moreno CAM; Silva AMS; Kouyoumdjian JA; Morita MDP; Reed UC; Lochmüller H; Zanoteli E
    Eur J Neurol; 2022 Mar; 29(3):833-842. PubMed ID: 34749429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital myasthenic syndromes.
    Hantaï D; Richard P; Koenig J; Eymard B
    Curr Opin Neurol; 2004 Oct; 17(5):539-51. PubMed ID: 15367858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital Myasthenic Syndromes.
    Iyadurai SJP
    Neurol Clin; 2020 Aug; 38(3):541-552. PubMed ID: 32703467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a
    Tan X; Hu S; Xie Z; Mei H; Liu Y; Yin L; Shi P; Chen Q; Sang D
    J Int Med Res; 2020 Sep; 48(9):300060520953643. PubMed ID: 32962503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
    Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
    J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype and phenotype analysis of patients with sporadic periodic paralysis.
    Sung CC; Cheng CJ; Lo YF; Lin MS; Yang SS; Hsu YC; Lin SH
    Am J Med Sci; 2012 Apr; 343(4):281-5. PubMed ID: 21841462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation.
    Vivekanandam V; Suetterlin K; Matthews E; Thornton J; Jayaseelan D; Shah S; Morrow JM; Yousry T; Hanna MG
    Muscle Nerve; 2023 Oct; 68(4):439-450. PubMed ID: 37515374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Normokalemic periodic paralysis lasting for two weeks: a severe form of sodium channelopathy with M1592V mutation].
    Shiga K; Mizuta I; Noto Y; Nakagawa M; Sasaki R; Yamawaki M
    Rinsho Shinkeigaku; 2014; 54(5):434-9. PubMed ID: 24943082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy.
    Compton AG; Albrecht DE; Seto JT; Cooper ST; Ilkovski B; Jones KJ; Challis D; Mowat D; Ranscht B; Bahlo M; Froehner SC; North KN
    Am J Hum Genet; 2008 Dec; 83(6):714-24. PubMed ID: 19026398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.
    Männikkö R; Wong L; Tester DJ; Thor MG; Sud R; Kullmann DM; Sweeney MG; Leu C; Sisodiya SM; FitzPatrick DR; Evans MJ; Jeffrey IJM; Tfelt-Hansen J; Cohen MC; Fleming PJ; Jaye A; Simpson MA; Ackerman MJ; Hanna MG; Behr ER; Matthews E
    Lancet; 2018 Apr; 391(10129):1483-1492. PubMed ID: 29605429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited disorders of the neuromuscular junction.
    O'Neill GN
    Int Anesthesiol Clin; 2006; 44(2):91-106. PubMed ID: 16849958
    [No Abstract]   [Full Text] [Related]  

  • 40. NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery.
    Groome JR; Lehmann-Horn F; Fan C; Wolf M; Winston V; Merlini L; Jurkat-Rott K
    Brain; 2014 Apr; 137(Pt 4):998-1008. PubMed ID: 24549961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.